AMANDA ROSEWELL SHAW to Treatment Outcome
This is a "connection" page, showing publications AMANDA ROSEWELL SHAW has written about Treatment Outcome.
Connection Strength
0.027
-
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Mol Ther. 2021 02 03; 29(2):505-520.
Score: 0.014
-
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Mol Ther. 2020 05 06; 28(5):1251-1262.
Score: 0.013